SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062041
Filing Date
2023-11-09
Accepted
2023-11-09 16:10:11
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K orgo-20231109.htm   iXBRL 8-K 49715
2 EX-99.1 orgo-ex99_1.htm EX-99.1 763424
3 GRAPHIC img36819578_0.jpg GRAPHIC 10498
  Complete submission text file 0000950170-23-062041.txt   981310

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgo-20231109_pre.xml EX-101.PRE 10675
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgo-20231109.xsd EX-101.SCH 2477
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgo-20231109_lab.xml EX-101.LAB 17195
8 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20231109_htm.xml XML 4518
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 231392457
SIC: 2834 Pharmaceutical Preparations